Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

Europe - EPA:AKE - FR0010313833 - Common Stock

50.925 EUR
-0.33 (-0.63%)
Last: 10/10/2025, 2:59:56 PM
Fundamental Rating

5

Overall AKE gets a fundamental rating of 5 out of 10. We evaluated AKE against 71 industry peers in the Chemicals industry. AKE has only an average score on both its financial health and profitability. AKE has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AKE had positive earnings in the past year.
In the past year AKE had a positive cash flow from operations.
AKE had positive earnings in each of the past 5 years.
In the past 5 years AKE always reported a positive cash flow from operatings.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

With a Return On Assets value of 1.51%, AKE perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
AKE has a Return On Equity of 2.90%. This is comparable to the rest of the industry: AKE outperforms 50.70% of its industry peers.
AKE's Return On Invested Capital of 3.44% is in line compared to the rest of the industry. AKE outperforms 53.52% of its industry peers.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 6.85%.
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROIC 3.44%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 2.22%, AKE perfoms like the industry average, outperforming 53.52% of the companies in the same industry.
In the last couple of years the Profit Margin of AKE has declined.
The Operating Margin of AKE (6.35%) is comparable to the rest of the industry.
AKE's Operating Margin has declined in the last couple of years.
AKE has a worse Gross Margin (19.02%) than 73.24% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
Industry RankSector Rank
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKE is still creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
AKE has less shares outstanding than it did 5 years ago.
AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 1.86 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKE has a Altman-Z score of 1.86. This is in the lower half of the industry: AKE underperforms 60.56% of its industry peers.
AKE has a debt to FCF ratio of 16.70. This is a negative value and a sign of low solvency as AKE would need 16.70 years to pay back of all of its debts.
AKE has a Debt to FCF ratio of 16.70. This is comparable to the rest of the industry: AKE outperforms 56.34% of its industry peers.
AKE has a Debt/Equity ratio of 0.50. This is a neutral value indicating AKE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.50, AKE is in line with its industry, outperforming 46.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Altman-Z 1.86
ROIC/WACC0.7
WACC4.9%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.73 indicates that AKE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.73, AKE belongs to the top of the industry, outperforming 80.28% of the companies in the same industry.
A Quick Ratio of 1.92 indicates that AKE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.92, AKE belongs to the top of the industry, outperforming 84.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.92
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.85%.
The Earnings Per Share has been growing slightly by 0.10% on average over the past years.
Looking at the last year, AKE shows a small growth in Revenue. The Revenue has grown by 0.19% in the last year.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-24.85%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-45.26%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.56%

3.2 Future

The Earnings Per Share is expected to decrease by -1.99% on average over the next years.
AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.69% yearly.
EPS Next Y-31.01%
EPS Next 2Y-7.63%
EPS Next 3Y-0.63%
EPS Next 5Y-1.99%
Revenue Next Year-3.76%
Revenue Next 2Y-0.47%
Revenue Next 3Y1.02%
Revenue Next 5Y1.69%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.98, the valuation of AKE can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 94.37% of the companies listed in the same industry.
AKE is valuated cheaply when we compare the Price/Earnings ratio to 27.70, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.27, which indicates a rather cheap valuation of AKE.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 98.59% of the companies are valued more expensively.
AKE is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.98
Fwd PE 7.27
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 94.37% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than the industry average as 78.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.06
EV/EBITDA 4.43
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)81.68
EPS Next 2Y-7.63%
EPS Next 3Y-0.63%

6

5. Dividend

5.1 Amount

AKE has a Yearly Dividend Yield of 6.69%, which is a nice return.
Compared to an average industry Dividend Yield of 3.05, AKE pays a better dividend. On top of this AKE pays more dividend than 95.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.69%

5.2 History

The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
AKE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-7.63%
EPS Next 3Y-0.63%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (10/10/2025, 2:59:56 PM)

50.925

-0.33 (-0.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners59.49%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.87B
Analysts75.24
Price Target77.66 (52.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.69%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-1.38%
PT rev (3m)-14.34%
EPS NQ rev (1m)-2.71%
EPS NQ rev (3m)-43.67%
EPS NY rev (1m)-3.09%
EPS NY rev (3m)-29.09%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-12.25%
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-5.32%
Valuation
Industry RankSector Rank
PE 7.98
Fwd PE 7.27
P/S 0.41
P/FCF 17.06
P/OCF 3.81
P/B 0.54
P/tB 1.81
EV/EBITDA 4.43
EPS(TTM)6.38
EY12.53%
EPS(NY)7.01
Fwd EY13.76%
FCF(TTM)2.98
FCFY5.86%
OCF(TTM)13.36
OCFY26.23%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)81.68
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.9%
ROCE 4.88%
ROIC 3.44%
ROICexc 3.86%
ROICexgc 7.22%
OM 6.35%
PM (TTM) 2.22%
GM 19.02%
FCFM 2.4%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.7
Debt/EBITDA 2.56
Cap/Depr 95.75%
Cap/Sales 8.36%
Interest Coverage 17.14
Cash Conversion 71.35%
Profit Quality 108.1%
Current Ratio 2.73
Quick Ratio 1.92
Altman-Z 1.86
F-Score5
WACC4.9%
ROIC/WACC0.7
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.85%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-45.26%
EPS Next Y-31.01%
EPS Next 2Y-7.63%
EPS Next 3Y-0.63%
EPS Next 5Y-1.99%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-5.56%
Revenue Next Year-3.76%
Revenue Next 2Y-0.47%
Revenue Next 3Y1.02%
Revenue Next 5Y1.69%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year49.9%
EBIT Next 3Y20.73%
EBIT Next 5Y12.38%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%